575 related articles for article (PubMed ID: 31209849)
1. Human Microbiota and Personalized Cancer Treatments: Role of Commensal Microbes in Treatment Outcomes for Cancer Patients.
Gately S
Cancer Treat Res; 2019; 178():253-264. PubMed ID: 31209849
[TBL] [Abstract][Full Text] [Related]
2. The impact of tumor and gut microbiotas on cancer therapy: Beneficial or detrimental?
Hekmatshoar Y; Rahbar Saadat Y; Hosseiniyan Khatibi SM; Ozkan T; Zununi Vahed F; Nariman-Saleh-Fam Z; Pourghassem Gargari B; Sunguroglu A; Zununi Vahed S
Life Sci; 2019 Sep; 233():116680. PubMed ID: 31344431
[TBL] [Abstract][Full Text] [Related]
3. Integration of microbiome and epigenome to decipher the pathogenesis of autoimmune diseases.
Chen B; Sun L; Zhang X
J Autoimmun; 2017 Sep; 83():31-42. PubMed ID: 28342734
[TBL] [Abstract][Full Text] [Related]
4. Current understanding of microbiota- and dietary-therapies for treating inflammatory bowel disease.
Eom T; Kim YS; Choi CH; Sadowsky MJ; Unno T
J Microbiol; 2018 Mar; 56(3):189-198. PubMed ID: 29492876
[TBL] [Abstract][Full Text] [Related]
5. Microbiota: a key orchestrator of cancer therapy.
Roy S; Trinchieri G
Nat Rev Cancer; 2017 May; 17(5):271-285. PubMed ID: 28303904
[TBL] [Abstract][Full Text] [Related]
6. The potential impact of gut microbiota on your health:Current status and future challenges.
Sirisinha S
Asian Pac J Allergy Immunol; 2016 Dec; 34(4):249-264. PubMed ID: 28042926
[TBL] [Abstract][Full Text] [Related]
7. Immunomodulatory potential of gut microbiome-derived short-chain fatty acids (SCFAs).
Ratajczak W; Rył A; Mizerski A; Walczakiewicz K; Sipak O; Laszczyńska M
Acta Biochim Pol; 2019 Mar; 66(1):1-12. PubMed ID: 30831575
[TBL] [Abstract][Full Text] [Related]
8. Fine-Tuning Cancer Immunotherapy: Optimizing the Gut Microbiome.
Pitt JM; Vétizou M; Waldschmitt N; Kroemer G; Chamaillard M; Boneca IG; Zitvogel L
Cancer Res; 2016 Aug; 76(16):4602-7. PubMed ID: 27474734
[TBL] [Abstract][Full Text] [Related]
9. Modulation of cancer immunotherapy efficacy by gut microbiota.
Huo S; Liu L; Liu J; Li Q; Wang J
Discov Med; 2019 Feb; 27(147):93-100. PubMed ID: 30939293
[TBL] [Abstract][Full Text] [Related]
10. Understanding the microbiome: Emerging biomarkers for exploiting the microbiota for personalized medicine against cancer.
Rajpoot M; Sharma AK; Sharma A; Gupta GK
Semin Cancer Biol; 2018 Oct; 52(Pt 1):1-8. PubMed ID: 29425888
[TBL] [Abstract][Full Text] [Related]
11. [The role of intestinal microbiota in the response to anti-tumor therapies].
Vétizou M; Daillère R; Zitvogel L
Med Sci (Paris); 2016 Nov; 32(11):974-982. PubMed ID: 28008838
[TBL] [Abstract][Full Text] [Related]
12. The microbiome and cancer for clinicians.
Picardo SL; Coburn B; Hansen AR
Crit Rev Oncol Hematol; 2019 Sep; 141():1-12. PubMed ID: 31202124
[TBL] [Abstract][Full Text] [Related]
13. The Influence of the Gut Microbiome on Cancer, Immunity, and Cancer Immunotherapy.
Gopalakrishnan V; Helmink BA; Spencer CN; Reuben A; Wargo JA
Cancer Cell; 2018 Apr; 33(4):570-580. PubMed ID: 29634945
[TBL] [Abstract][Full Text] [Related]
14. Impact of gut microbiome in the development and treatment of pancreatic cancer: Newer insights.
Bangolo AI; Trivedi C; Jani I; Pender S; Khalid H; Alqinai B; Intisar A; Randhawa K; Moore J; De Deugd N; Faisal S; Suresh SB; Gopani P; Nagesh VK; Proverbs-Singh T; Weissman S
World J Gastroenterol; 2023 Jul; 29(25):3984-3998. PubMed ID: 37476590
[TBL] [Abstract][Full Text] [Related]
15. The microbiome, cancer, and cancer therapy.
Helmink BA; Khan MAW; Hermann A; Gopalakrishnan V; Wargo JA
Nat Med; 2019 Mar; 25(3):377-388. PubMed ID: 30842679
[TBL] [Abstract][Full Text] [Related]
16. Gut Microbiota as a Positive Potential Therapeutic Factor in Carcinogenesis: an Overview of Microbiota-Targeted Therapy.
Joukar F; Mavaddati S; Mansour-Ghanaei F; Samadani AA
J Gastrointest Cancer; 2020 Jun; 51(2):363-378. PubMed ID: 31025167
[TBL] [Abstract][Full Text] [Related]
17. Gut microbiome and response to checkpoint inhibitors in non-small cell lung cancer-A review.
Nagasaka M; Sexton R; Alhasan R; Rahman S; Azmi AS; Sukari A
Crit Rev Oncol Hematol; 2020 Jan; 145():102841. PubMed ID: 31884204
[TBL] [Abstract][Full Text] [Related]
18. Targeted modulation of gut and intra-tumor microbiota to improve the quality of immune checkpoint inhibitor responses.
Wang W; Fan J; Zhang C; Huang Y; Chen Y; Fu S; Wu J
Microbiol Res; 2024 May; 282():127668. PubMed ID: 38430889
[TBL] [Abstract][Full Text] [Related]
19. The Impact of Intratumoral and Gastrointestinal Microbiota on Systemic Cancer Therapy.
Cogdill AP; Gaudreau PO; Arora R; Gopalakrishnan V; Wargo JA
Trends Immunol; 2018 Nov; 39(11):900-920. PubMed ID: 30392721
[TBL] [Abstract][Full Text] [Related]
20. Molecular Paths Linking Metabolic Diseases, Gut Microbiota Dysbiosis and Enterobacteria Infections.
Serino M
J Mol Biol; 2018 Mar; 430(5):581-590. PubMed ID: 29374557
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
